Pediatrics News

Young adults with childhood history of both parental incarceration and juvenile justice involvement were more likely to have depression, anxiety or PTSD compared to those without either exposure, according to a study published in JAMA Network Open.

Kids diagnosed with inflammatory bowel disease, or IBD, are at increased risk for psychiatric disorders later in life, especially those who were diagnosed before age 6 years, according to findings published in JAMA Pediatrics.

Psychotic-like experiences, circadian disturbances, poorer social function and manic-like experiences were linked to illness progression in a longitudinal cohort study of youth who presented to early intervention services for psychiatric disorders.

U.S. Surgeon General Jerome Adams, MD, issued an advisory to raise awareness — especially among pregnant women and youth — of the harms associated with marijuana use.

Offspring born via cesarean delivery were at increased risk for autism spectrum disorder and ADHD compared with those born by vaginal delivery, findings published in JAMA Network Open revealed.

A review published in Pediatrics revealed gaps and inconsistencies in findings about the outcomes of children exposed to opioids prenatally and those born with neonatal abstinence syndrome, or NAS.

Methylphenidate — a drug used to treat ADHD — may affect specific tracts in brain white matter in boys with the disorder, according to findings from a randomized control trial conducted in the Netherlands. The results published in Radiology suggest that the effects are age dependent.

Thyroid-stimulating hormone concentrations were abnormal in about 6% of psychiatrically hospitalized youth with significant mood and anxiety disorders, but thyroid disease was present in less than 1% of the total sample, according to study findings.

Findings from a prospective, multicenter birth cohort study published in JAMA Pediatrics suggested that maternal exposure to fluorinated water during pregnancy is associated with a decrease the IQ scores of children.

Adding fluoxetine to cognitive behavioral therapy failed to further decrease depressive symptoms in youth with moderate-to-severe major depressive disorder, according to findings published in Lancet Psychiatry.